Glycopyrrolate Patents

Given below is the list of patents protecting Glycopyrrolate, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Glycopyrrolate's patents.

Latest Legal Activities on Glycopyrrolate's Patents

Given below is the list recent legal activities going on the following patents of Glycopyrrolate.

Activity	Date	Patent Number
Critical Events for all Patents
Maintenance Fee Reminder Mailed Critical	24 Jun, 2024	US8303991(Litigated)
Expire Patent Critical	04 Dec, 2023	US8048451
Maintenance Fee Reminder Mailed Critical	19 Jun, 2023	US8048451
Expire Patent Critical	27 Mar, 2023	US8956661
Payment of Maintenance Fee, 12th Year, Large Entity	22 Mar, 2023	US8029768
Maintenance Fee Reminder Mailed Critical	10 Oct, 2022	US8956661
Expire Patent Critical	18 Jul, 2022	US7736670
Expire Patent Critical	13 Jun, 2022	US9962338
Expire Patent Critical	10 May, 2022	US9931304
Maintenance Fee Reminder Mailed Critical	31 Jan, 2022	US7736670

Glycopyrrolate's Family Patents

Full family tree